Amid a surge of COVID-19 cases in India and other parts of the world, the Biden administration remains noncommittal on a proposal to loosen patent restrictions so that countries can manufacture generic versions of the coronavirus vaccines. White House correspondent Patsy Widakuswara has this report.
…
your ad here
